Krebs Biochemicals & Industries has received an approval for raising of funds by way of offer and issue of Equity Shares to the members of the company on rights basis (Rights Issue) at such price and rights entitlement ratio as may be decided by the Board/committee of the Board, for an amount aggregating up to Rs 25 crore. The Board of Directors of the company in its meeting on July 30, 2018, approved the same.
Krebs Biochemicals & Industries is an India-based company. The Company operates in the pharma segment.